Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

Published:2014-09-09 Issue:2 Volume:121 Page:226-233
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chen Yi-Bin¹,Batchelor Tracy²,Li Shuli³,Hochberg Ephraim⁴,Brezina Mark⁴,Jones Sooae²,Del Rio Candice¹,Curtis Morgan¹,Ballen Karen K.¹,Barnes Jeffrey⁴,Chi Andrew S.²,Dietrich Jorg²,Driscoll Jessica¹,Gertsner Elizabeth R.²,Hochberg Fred²,LaCasce Ann S.⁵,McAfee Steven L.⁴,Spitzer Thomas R.⁴,Nayak Lakshmi⁶,Armand Philippe⁵

Affiliation:

1. Bone Marrow Transplant Unit; Massachusetts General Hospital; Boston Massachusetts

2. Division of Neuro-Oncology; Massachusetts General Hospital; Boston Massachusetts

3. Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute; Boston Massachusetts

4. Division of Hematology/Oncology; Massachusetts General Hospital; Boston Massachusetts

5. Division of Hematological Malignancies; Dana-Farber Cancer Institute; Boston Massachusetts

6. Division of Neuro-Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07;Batchelor;J Clin Oncol,2003

2. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10;DeAngelis;J Clin Oncol,2002

3. Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation;Gerstner;Neurology,2008

4. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962;Poortmans;J Clin Oncol,2003

5. Long-term survival in primary CNS lymphoma;Abrey;J Clin Oncol,1998

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma;Blood;2024-07-25

2. The notable outcomes of modified thiotepa-based conditioning followed by autologous stem cell transplantation in primary central nervous system lymphomas: A real-life pilot study;2024-05-31

3. Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia;Bone Marrow Transplantation;2024-05-16

4. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma;European Journal of Cancer;2024-01

5. Successful treatment of isolated central nervous system recurrence of primary testicular lymphoma by autologous stem cell transplantation using a conditioning regimen of thiotepa and busulfan;Journal of Clinical and Experimental Hematopathology;2024